[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.176.252. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1955

Permanent Bilateral Blindness Following the use of Hexamethonium Chloride

Author Affiliations

New York
From the Institute of Ophthalmology of the Presbyterian Hospital.

AMA Arch Ophthalmol. 1955;54(3):422-424. doi:10.1001/archopht.1955.00930020428014
Abstract

Hexamethonium chloride is a quaternary ammonium halide. Its formula is:

Sometimes the bromide is employed and in England the iodide is preferred, but the chloride is the most commonly used salt.

In the United States hexamethonium is sold as Methium (Warner-Chilcott Laboratories), Hexameton (Burroughs Wellcome & Company), Esomid (Ciba Pharmaceutical Products, Inc.), Bistrium (E. R. Squibb & Sons), and others. It is also combined with such antihypertensive drugs as hydralazine (Apresoline) and rauwolfine.

The tetra-, penta-, and hexamethonium compounds act by blocking both the sympathetic and the parasympathetic ganglia. The block, which is carried out by competition, occurs at the synapse. Vasoconstriction and autonomie tone are thereby reduced or abolished. In addition to use of hexamethonium in hypertension, the drug is being widely used in surgery, particularly in extensive operations, to diminish bleeding. As might be expected in a drug that may cause a fall of blood pressure from 260/160

First Page Preview View Large
First page PDF preview
First page PDF preview
×